Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection - Wikidata - awgldk - TriplyDB

Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection

Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection

http://www.wikidata.org/entity/Q36718058

about

Perspectives on menopause and women with HIV HIV infection and osteoporosis HIV infection and older Americans: the public health perspective Screening for chronic comorbid diseases in people with HIV: the need for a strategic approach Does HIV infection have an impact upon dental implant osseointegration? A systematic review HIV infection and bone disease.Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life.Lifetime and recent alcohol use and bone mineral density in adults with HIV infection and substance dependence Incident fractures in HIV-infected individuals: a systematic review and meta-analysis Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial.Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.Increased risk of fragility fractures among HIV infected compared to uninfected male veterans.Prospective study of bone mineral density changes in aging men with or at risk for HIV infection.Mucosal immunity in human and simian immunodeficiency lentivirus infections Reduced quantitative ultrasound bone mineral density in HIV-infected patients on antiretroviral therapy in Senegal.Association of age and comorbidity with physical function in HIV-infected and uninfected patients: results from the Veterans Aging Cohort Study Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women.Bone disease in HIV infection: a practical review and recommendations for HIV care providers.Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study.Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.The unsolved case of "bone-impairing analgesics": the endocrine effects of opioids on bone metabolism.Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss.Characteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy.Bone disease in HIV infection.Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study.Nonsurgical Management of Severe Osteonecrosis of the Knee in an HIV-Positive Patient: A Case Report.Increased Fracture Incidence in Middle-Aged HIV-Infected and HIV-Uninfected Women: Updated Results From the Women's Interagency HIV Study Care of the human immunodeficiency virus-infected menopausal woman.Quantitative MRI and spectroscopy of bone marrow.Microbial translocation across the GI tract HIV and bone metabolism Serum Sclerostin Levels in Patients with Human Immunodeficiency Virus Infection and Their Association with Bone Turnover Markers and Bone Mineral Densitometry Impact of age on markers of HIV-1 disease HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture.Physiologic frailty and fragility fracture in HIV-infected male veterans Functional impairment is associated with low bone and muscle mass among persons aging with HIV infection.Trabecular and cortical microarchitecture in postmenopausal HIV-infected women.Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy

P2860

Q26772852-3135471B-7F6C-4E0B-A961-E8C08571CFC0 Q26853139-1D3CEC81-87BC-4587-89D3-A18A7C1A594C Q26858824-062F0E08-C167-40EC-AC1F-F435B0EC40C4 Q26866452-6D0B2B68-1068-49E7-9B02-7F285FFB59F6 Q27021653-6C5477CE-8AB3-4354-91BC-438CAD896486 Q30249771-7A1D1D04-F235-44AF-832C-E7EC105736B2 Q33603221-1B1782F0-0075-484C-ADCD-9B3F5706068B Q33627227-352B9D09-8CC6-4B48-9DE2-A392141447B8 Q33648297-0A26167C-0EAE-476D-A234-DD6AA42A5523 Q33665210-513BFBC5-6E69-4F50-8311-8B3248BD3299 Q33736156-ED1F2B07-5688-445D-B412-E668FE752452 Q33794374-F9E2C352-D2F2-46B1-BD54-5566EADFB07B Q33832012-8C9EADB1-03AC-4D22-84D9-F4F7FE2FC3B6 Q34116648-BD3F39E7-387E-443A-852E-F26556DC7E4F Q34131265-E9078BE4-0118-4549-B359-C1CD900BB30F Q34168353-318489AD-4ABE-48E0-A4A7-E7716E035FA3 Q34539483-744D94FE-FF67-4311-9EF2-2E4BF771781D Q35019046-E48C499C-7808-45A0-A49A-A5A85D9D0298 Q35019051-189019ED-1AB6-4855-8E73-E6733613EC7F Q35024409-E9A9EA23-27FE-4D87-9DC6-BF501A2FF56B Q35104006-029F730A-5ED9-4AA6-BC16-B012AA650382 Q35124970-15BCF873-03D4-4DE7-8B6A-04631F4679F1 Q35284151-C92BE141-42EA-4FB8-A015-70B0CD2FB58F Q35291766-909D43A1-9484-4F58-9697-76659785C051 Q35557338-29732E7C-ACE9-4A87-8CE6-F2530F5666ED Q35593296-C174125E-CD17-4B57-B54C-058BB5CE2EF3 Q35744467-247767BD-FCBE-48CE-98C6-D8B4E4B05B07 Q35912158-F8F136B9-EC32-4C66-8BAF-B5B982ADD689 Q36019580-C9E518A4-8BEA-450F-B213-BE267259F02D Q36128333-E20E01D3-D39C-4ADC-9F53-97178647B66D Q36389213-938EB5A7-B588-45EB-A47F-58794C923AFF Q36441742-60250359-1B22-41A8-A259-C77DF8D9E489 Q36671233-B23F5DE5-64BB-4A3E-9E3F-F43D63193133 Q36685956-686C2917-6B8A-40A3-A2BD-8537A399A470 Q36763762-2ACD8BC4-4E12-46B0-B687-4E81977A8100 Q36783435-24147711-08AF-4E7B-B9EA-A2317BBF84C6 Q36789908-A3EDC89C-822B-44AB-B8E9-827BD7223536 Q36844115-285584E0-5C4C-4987-858C-DE753F59D4F6 Q36849920-F9B98AAE-C824-43A9-B952-2CBC07FBDA0E Q36853309-06A6A55D-86E1-484C-AD99-0789AD4352AB

P2860

Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection

http://www.wikidata.org/entity/Q36718058

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Decreased bone mineral density ...... h or at risk for HIV infection

@ast

Decreased bone mineral density ...... h or at risk for HIV infection

@en

type

label

Decreased bone mineral density ...... h or at risk for HIV infection

@ast

Decreased bone mineral density ...... h or at risk for HIV infection

@en

prefLabel

Decreased bone mineral density ...... h or at risk for HIV infection

@ast

Decreased bone mineral density ...... h or at risk for HIV infection

@en

P1433

Q36718058-1ED4064A-0157-4399-B892-99F1BEE95084

P1476

Q36718058-27F29BEE-F538-4F89-B97D-1546EA5CD093

P2093

Q36718058-3676E5F9-7E11-47F4-A7C1-C510E2F2E3F7

Q36718058-7FAE93A0-BF04-4CD3-9124-F88BCC167E8B

Q36718058-93ABD9AA-B6E0-458A-8524-B70E4C05FB05

Q36718058-C2371BE9-DA7C-45F3-B964-1F2C35B7AC38

Q36718058-DF63DC4F-280E-4C0A-B383-FA174C53EDC2

Q36718058-E8E03BC1-9001-4D8D-B74E-92ABDAF833B8

P2860

Q36718058-05678823-3A11-4234-9124-7DB5C268B4F9

Q36718058-0E9250AB-F384-44E1-B4FB-532F9283C95D

Q36718058-100AC8D5-DBA1-4269-8A07-CFE52459DAD2

Q36718058-1B451C88-CE82-490E-8998-68E70A62D59D

Q36718058-1FD4559C-DD7D-4744-B057-0DA3E2455C00

Q36718058-2F5026E9-217A-421B-879D-9BAD6A0F65BE

Q36718058-444F64DE-A32D-4348-9FEA-F8D9445763B8

Q36718058-4A150C4E-CAF8-4134-8B2E-EF5292CD5633

Q36718058-519B69AC-3E94-4ECD-AEC1-964A1CACF8E7

Q36718058-55F7A58E-89FE-410A-8609-FB2B245411D7

P304

Q36718058-3A118176-AF24-450D-A479-6DC0A891B487

P31

Q36718058-272F471E-ABD1-4EB2-98C8-8DD152F365C5

P356

Q36718058-E03D3361-2843-470E-827A-2C29DF673DF2

P407

Q36718058-D91CF5B7-8D41-45F3-9142-A8B1278EDA95

P433

Q36718058-1A62BF80-6A64-4DEC-9060-35C674A0609D

P478

Q36718058-1041CC74-1247-431E-92E6-4E504B65F916

P577

Q36718058-B2EF3D92-9139-464B-A78C-6A995FBCB751

P698

Q36718058-2D14FB4A-E4EE-48C3-9DCE-FC4AFA6BD259

P932

Q36718058-842CE686-5904-4A79-B985-B407FD387D7C

P356

QAD.0B013E3280148C05

P1433

P1476

Decreased bone mineral density ...... h or at risk for HIV infection

@en

P2093

Andrea A Howard

http://www.w3.org/2001/XMLSchema#string

Julia H Arnsten

http://www.w3.org/2001/XMLSchema#string

Michelle Floris-Moore

http://www.w3.org/2001/XMLSchema#string

Robert S Klein

http://www.w3.org/2001/XMLSchema#string

Ruth Freeman

http://www.w3.org/2001/XMLSchema#string

Yungtai Lo

http://www.w3.org/2001/XMLSchema#string

P2860

Determinants of peak bone mass and mechanisms of bone loss.

Body composition and nutritional parameters in HIV and AIDS patients.

Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease.

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

Sex steroids and bone mass. A study of changes about the time of menopause

A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect

Androgen levels in older men who have or who are at risk of acquiring HIV infection.

Prevalence and predictive value of overweight in an urban HIV care clinic.

Epidemiology of osteoporosis and osteoporotic fractures.

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis.

P304

617-623

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0B013E3280148C05

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17314524

http://www.w3.org/2001/XMLSchema#string

P932

2426821

http://www.w3.org/2001/XMLSchema#string